Pfizer cervical cancer drug gets full approval April 30, 2024 AutoBot Uncategorized 0 The FDA has granted full approval for Pfizer’s Tivdak (tisotumab vedotin-tftv) to treat cervical cancer in patients whose disease has progressed on or after chemotherapy.